Artemis Medicare Services Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on July 30, 2025. Further, the company has informed the Exchange regarding voting results.
ARTEMISMED · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Artemis Medicare Services Limited held its 21st AGM on July 30, 2025, and shareholders approved all 6 resolutions with near-unanimous support. Total votes polled were 10,19,45,488, representing 73.38% of outstanding shares (13,89,32,250). Key items included adoption of audited financial statements for FY25 (100% in favor), declaration of a final dividend of Re. 0.45 per equity share (100% in favor), and re-appointment of Mr. Neeraj Kanwar as Director (99.95% in favor). Other approvals covered ratification of Cost Auditor remuneration, appointment of Mr. Sunam Sarkar as Non-Executive Non-Independent Director (99.95% in favor), and appointment of M/s. DMK Associates as Secretarial Auditors. The Scrutinizer's report from DMK Associates confirmed the e-voting process as fair and transparent.
Shareholders can expect the declared final dividend of Re. 0.45 per share for FY25. The smooth clearance of all resolutions, including director appointments and auditor ratifications, signals strong shareholder confidence and stable governance, with no negative material impact expected on the stock.